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Abstract: Peptide microarrays are a fast-developing field enabling the mapping of linear epitopes in
the immune response to vaccinations or diseases and high throughput studying of protein-protein
interactions. In this respect, a rapid label-free measurement of protein layer topographies in the
array format is of great interest but is also a great challenge due to the extremely low aspect ratios
of the peptide spots. We have demonstrated the potential of vertical scanning interferometry (VSI)
for a detailed morphological analysis of peptide arrays and binding antibodies. The VSI technique
is shown to scan an array area of 5.1 square millimeters within 3–4 min at a resolution of 1.4 µm
lateral and 0.1 nm vertical in the full automation mode. Topographies obtained by VSI do match
the one obtained by AFM measurements, demonstrating the accuracy of the technique. A detailed
topology of peptide-antibody layers on single spots was measured. Two different measurement
regions are distinguished according to the antibody concentration. In the case of weakly diluted
serum, the thickness of the antibody layer is independent of the serum dilution and corresponds to
the physical thickness of the accumulated antibody layer. In strongly diluted serum, the thickness
measured via VSI is linearly proportional to the serum dilution.
Keywords: peptide array; vertical scanning interferometry; atomic force microscopy; serum antibodies
1. Introduction
The study of peptide-protein interactions in high-density array formats is an efficient way
to investigate the binding specificity of protein interaction domains such as WW, SH3, and PDZ
domains [1], and to develop novel diagnostics based, for instance, on the detection of specific serum
antibodies [2]. The array format enables multiplexed high-throughput assays and requires minimal
sample volume [3]. Hereby, the binding events between the proteins and the peptide spots assembled
on a substrate are frequently detected using fluorescent labels. Although the labeling of proteins is a
well-established procedure, important information about the interactions between biological molecules
and the homogeneity of the binding events can be lost. In addition, the labels can influence the protein
affinity that may lead to unspecific binding. However, direct application of the known label-free
detection methods, such as surface plasmon resonance methods [4–6], reflectometric interference
spectroscopy [7], or resonator-like microstructures [8], is not possible for the surfaces on which
commercially available high-density peptide arrays are synthesized. The transfer of the peptide spots
to the standard free-label detection surfaces from a synthesis surface seems to be a very complicated
procedure due to the spreading of the peptides cleaved and their amino-acid-dependent diffusion and
adsorption [9].
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Parallel to developments of high-density arrays, optical scanning techniques such as vertical
scanning interferometry (VSI) have experienced huge progress in the last decade in terms of
scanning velocity and scanning area. Imaging of protein layers with an optical microscope for the
characterization of peptide microarrays has been reported on antireflection substrates [10]. In contrast,
the VSI technique is independent of specific substrate coatings suited for glass substrates common
for molecular arrays and allows a vertical and lateral resolution down to the nanometer range [11].
A significant enhancement in the spatial resolution of a VSI method was achieved via sub-pixel sample
positioning [12] or the use of a dual wavelength white light emitting diode as a light source [13].
The maximal lateral VSI resolution of ~ 20 nm was theoretically predicted [14]. Some studies report
the use of VSI to characterize surface roughness of membranes [15] and engineering surfaces [16],
as well as topographic and geometric investigations of cells [17]. But, according to our knowledge,
the VSI method has not yet been explored for label-free detection of peptide-antibody interactions.
To estimate the feasibility of the VSI technique for this application, we focus on the measurement
of antibody layer thickness accumulated in the high-density array format. For this purpose, the protein
layer thickness resulting from the incubation of serum reactive peptide spots with different dilutions of
serum and secondary antibody were compared with the fluorescent signal intensities. To evaluate the
accuracy of VSI measurements, peptide spots are additionally scanned via an atomic force microscope,
and layer profiles of both VSI and AFM measurements are compared.
2. Materials and Methods
2.1. Array Assembling: Peptide Array, Antibodies and Incubation of Peptide Arrays
Peptide arrays were produced by spotting pre-synthesized peptides containing a C-terminal
cysteine onto 3D-Maleimide glass surfaces (PolyAn, Berlin, Germany) (Figures 1 and 2). This surface
serves as a model surface for the peptide arrays synthesis. Glycine-serine-glycine-serine was
synthesized as a spacer between the C-terminal cysteine and the actual peptide sequence.
A serum reactive peptide (MVPEFSGSFPMRGSGSC) [18] and the synthetic peptide containing the
hemagglutinin (HA) fragment of an influenza virus (YPYDVPDYAGGSGSC) [19] (Peps4LS, Heidelberg,
Germany) were dissolved into phosphate buffered saline (PBS) at pH 7.4 (Sigma-Aldrich, St. Louis, MO,
USA) to concentrations of 0.4 mM, 0.2 mM, and 0.1 mM. Tris(2-carboxyethyl)phosphonium chloride
(TCEP) was added to 50 µL of a peptide solution. Spotting was conducted with a NanoPlotter 2.1
(GeSiM, Radeberg, Germany) using the Pico Tip J A070-402 p00738A. For each spot, two drops
of approximately 400 pl peptide solution were deposited. Peptides were covalently bound by a
thiol-maleimide click reaction [20]. After spotting, the slides were dried for 2 h and subsequently
blocked in PBS containing 0.4% 2-Mercaptoethanol (Merck, Darmstadt, Germany). The washing was
performed at 70 rpm on an orbital shaker (Orbital Shaker DOS-20S, Elmi Ltd., Riga, Lettland) for 3 min
with PBS, 3 min deionized water, 5 min acetonitrile (VWR Chemicals, Missouri, TX, USA) containing
0.1% Trifluoroacetic acid (99%) (Honeywell Chemicals, Mexico City, Mexico), 5 min DMF (99.8%) (VWR
Chemicals, Radnor, PA, USA) containing 0.5% DIPEA (Merck, Darmstadt, Germany), 3 min × 5 min
DMF and 2 min × 3 min Methanol (Merck, Darmstadt, Germany). Slides were dried in an argon gas
stream and stored at 4 ◦C until further usage.
The donation of serum by a human individual was approved by the state chamber of physicians of
Baden-Wuerttemberg (reference number: F-2011-044) and informed consent was obtained. To visualize
the serum antibodies bound to the serum reactive peptide, a secondary antibody (Goat anti-human
IgG (FC γ) AF647, Jackson Immunoresearch, Bothell, WA, USA) was used at a concentration of
13.3 nM. Monoclonal anti-HA antibody, (provided by Dr. Gerd Moldenhauer from DKFZ, Heidelberg,
Germany), diluted to 1 µg/µL was conjugated to the fluorophores DL550 NHS esters (DyLight 550 NHS
ester, Thermo Fisher Scientific, Waltham, MA, USA) according to the instructions.
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Peptide arrays were incubated according to the protocol published by Weber et al. [18] using PBS-T
(PBS containing 0.05% Tween 20 (Sigma Aldrich, St. LouisCity, MO, USA)) for the dilution of antibodies.
The incubation of primary antibodies was conducted overnight at 4 ◦C. Unbound antibodies were
removed by washing with PBS-T, and the secondary antibody was incubated for 30 min followed by
washing. All incubations were conducted under agitation using an orbital shaker with a rotation speed
of 140 rpm. The arrays were dried in an argon gas stream, and a fluorescence scan, as well as AFM and
VSI measurements, were performed.High-Throughput 2019, 8 FOR PEER REVIEW  3 
 
 
Figure 1. Immobilization of HA-tag and serum reactive peptide (SRP) on 3D Maleimide surfaces 
using spotting and incubation with antibodies. (A): Pre-synthesized peptides are dissolved in PBS 
and are deposited onto the functionalized surface as drops using a spotting robot. (B): Peptides 
contain a C-terminal cysteine and bind covalently to the synthesis film by a thiol-maleimide click 
reaction. (C): Peptide array incubated with human blood serum and at a low concentration 
fluorescently labeled anti-HA antibody overnight. Antibodies from the sample bind to the peptides. 
(D): Unbound serum and HA-antibodies are removed by washing and the peptide array is incubated 
with fluorescently-labeled, anti-human secondary antibody for fluorescence detection. 
 
Figure 2. The Peptide array setup. (A): The area of the peptide array is divided into 16 subarrays 
using press-on sealing. Seven different serum dilutions are incubated on two subarrays each. White 
colored subarrays represent controls incubated with PBS-T. (B): The spotting schemes of each 
subarray. Three different peptide concentrations are spotted with nine spots each. White colored 
spots represent controls, spotted using PBS only. 
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Figure 1. Immobilization of HA-tag and serum reactive peptide (SRP) on 3D Maleimide surfaces
using spotting and incubation with antibodies. (A): Pre-synthesized peptides are dissolved in PBS
and are deposited onto the functionalized surface as drops using a spotting robot. (B): Peptides
contain a C-terminal cysteine and bind covalently to the synthesis film by a thiol-maleimide click
reaction. (C): Pep ide array incubated with human blood serum and at a low concentration
fluorescently labeled anti-HA antibody overnight. Antibodies from the sample bind to the peptides.
(D): Unbound serum and HA-antibodies are removed by washing and the peptide array is incubated
with fluorescently-labeled, anti-human secondary antibody for fluorescence detection.
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Figure 2. The Peptide array setup. (A): The area of the peptide array is divided into 16 subarrays using
press-on sealing. Seven different serum dilutions are incubated on two subarrays each. White colored
subarrays represent controls incubated with PBS-T. (B): The spotting schemes of each subarray.
Three different peptide concentrations are spotted with nine spots each. White colored spots represent
controls, spo ted using PBS only.
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2.2. Array Fluorescence Scanning
Fluorescence scanning was performed on the Innoscan 1100 AL (Innopsys, Carbonne, France) at
647 nm, gain 3, laser power low, and a resolution of 1 µm/pixel. The resulting 16-bit grayscale images
were analyzed using Mapix (Innopsys, Carbonne, France). The median gray scale value of all pixels in
a spot was subtracted by the median gray scale value of at least 5 background control areas (spot size
of 80–90 µm each), located in the vicinity of the spot of interest.
2.3. Vertical Scanning Interferometry (VSI)
Spot topology was imaged by the Contour GT-K by Bruker using Vertical Scanning Interferometry
(VSI) in VXI mode for higher z-resolution at ambient conditions.
A scheme of the setup can be seen in Figure 3. VSI uses the interference of two coherent beams of
light to determine differences in their optical path lengths. For this purpose, a beam of light is emitted
by a light source and separated by a beam splitter, located in the Mirau objective, into a sample and
a reference beam. The sample beam passes the splitter and is reflected off the sample surface and
directed back to the objective, whereas the reference beam is reflected off the splitter. The beams are
directed back together and form an interference pattern of dark and light fringes, which are sampled
by a CCD camera. The obtained interferograms are analyzed by software to calculate the surface
height pixel by pixel, and topographic 3D models are generated. With 1.7 mm by 1.3 mm dimensions,
the setup offers a big field of view in relation to a subnanometer z-resolution. Therefore, a large
area scan of an array of 11 × 29 spots is conducted and spot properties are evaluated for quality
control. The green light source was selected, the back scan was set to 3 microns, and the number of
measurements to average was set to 3 at auto resolution. To reduce noise and improve image quality,
the device was operated on a vibration-dampening table. For the 5× objective, the field of view was
1.75 mm by 1.3 mm. To image an array with the area of 3 mm by 1.75 mm, 3 measurements were
automatically stitched together, applying an overlap of 23%. Measurements were flattened in Vision64,
applying an operational F-filter using the ‘tilt only’ option. Additionally, dust particles were masked
via histogram. Median spot heights were obtained by the ‘multiple region’ option, where the leveling
was set to auto, and the threshold for height and number of contiguous pixels was set depending on
the analysis conducted.
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3D models are calculated [21].
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2.4. Atomic Force Microscopy (AFM)
All AFM measurements were performed under ambient conditions with a Bruker Dimension
Icon AFM. The measurements were conducted in ScanAsyst mode using ScanAsyst-Air cantilevers
(Bruker, Billerica, MA, USA) with a resonance frequency of about 150 kHz and a scan speed of 0.15 Hz.
The offline image flattening and analysis were performed with the NanoScope Analysis software
(Version 8.4, provided via Software Downloads—Service of Bruker, Billerica, MA, USA).
2.5. Comparison of AFM and VSI Measurements Force Microscopy (AFM)
For the comparison of spot topologies measured with AFM and VSI, the respective measurements
were imported into Gwyddion 2.49 [22]. Minimal z-values were set to zero and a third-degree
polynomial background correction was conducted. Data sets were exported as text files and further
processed in Matlab 14a. For alignment, the position of a prominent feature in the middle of the spot
was used as the zero point. Measurements were set up to be congruent to each other, so no rotational
correction was needed in post-processing. This was accomplished by reference markers located some
millimeters next to the structures of interest. Considering the respective resolution, line profiles were
extracted, intersecting the spots vertically and horizontally.
2.6. Determining Antibody Profiles for VSI Measurements
For each level of serum dilution, 9 spots were measured using VSI as described above.
The medium spot heights were determined using the multiple region option in Vision64,
which identifies all areas matching the threshold criteria in height and amount of contiguous pixels.
Thresholds for each dilution level were set to maintain a constant number of pixels per spot.
3. Results and Discussion
3.1. Fast Scanning Large Field of View Using VSI
A peptide array consisting of 16 subarrays of 11 × 29 peptide spots each was produced, incubated
with serum and antibodies and imaged by VSI. Peptides were deposited onto the functional surface by
spotting HA peptide and serum peptides at a concentration of 400 µM onto a 3D-Maleimide surface.
The serum reactive peptide pattern has the form of the KIT symbol, while other spots, supplementing
the rectangular subarray, were HA peptides. The array was incubated with serum (diluted 1:50)
and anti-HA antibody DL550 (13.3 fM) overnight and then with fluorescently-labeled anti-human
secondary antibody (AF647) at 13.3 nM for 30 min. The concentration of anti-HA antibody added was
chosen to be two magnitudes lower than the concentration of secondary antibody to see if the anti-HA
antibody was still detectable using VSI. A scheme of peptide deposition and antibody incubation
is depicted in Figure 1. The whole slide was scanned by VSI to determine the coordinates of each
pattern relative to two corners of the 3D-Maleimide slide and to image the individual patterns by
stitching 3 measurements. For perfectly plane and smooth surfaces, areas being multiples of the field of
view (1.7–1.3 mm) can be scanned by stitching individual measurements together without readjusting
focus. In Figure 4, one of the 16 patterns is shown (see also a corresponding fluorescent image in
Figure S1, supplementary data). It was possible to resolve spot heights in a z-range of 7 nm, while the
lateral size of the measurement is in the millimeter scale. Small imperfections of the functionalized
surface are visible, which would remain undetected using fluorescence images. Even the anti-HA
antibody-HA peptide spots are vaguely perceptible in between the plainly visible serum spots in the
3D visualization. The height profile drawn across the array in Figure 4C shows the ratio in height
of HA spots to incubated SRP spots, which is about ~1–7. A more detailed evaluation of SPR spot
properties is shown in Figure 4D. Applying a threshold of 1 nm and a minimum of 1000 contiguous
pixels, all 125 SRP spots are captured. The mean spot height is distributed between 2 and 3.5 nm
corresponding to a spot area of 1800–4200 pixels, whereas the spot diameter ranges from 70–100 µm.
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This rather broad distribution results to some extent from the zero-level applied for the calculation,
which was averaged for all non-spot areas.
This experiment, demonstrating the possibility of both the detection of antibody layers in spots in
a high-density array format and distinguishing between different antibody binders, reveals a principle
question about the physical meaning of the thickness observed via VSI. The antibodies are known to
be Y-shaped proteins with the dimensions 14.5 nm × 8.5 nm × 4.0 nm [23]. The observed thickness
of the SPR spots in a range of 3 nm is significantly smaller than the thickness of 8 nm in the case of
assembling the primary and secondary antibodies flat on each other on the surface. The reason why
the measured thickness of antibody layers does not correspond to the dimensions of an IgG might
be, for one, due to the ability of the antibody to migrate to some extent into the polymer layer onto
which the peptides are immobilized (also peptides migrate into the polymer during immobilization).
Apparently, the concentration of antibodies should have a significant influence on the thickness of
the antibody layer. To answer this question, the thickness of the accumulated antibody layers was
measured at different serum dilutions.
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3.2. Qualitative Comparison Between VSI and Fluorescence-Based Detection
The detection of peptide-bound antibody is usually realized via fluorescence since it is very
sensitive. The antibody is, therefore, conjugated to a dye acting as a fluorescent label. At higher
concentrations of labeled antibody, the fluorescence intensity does not correlate any more with the
amount of adsorbed antibody due to a self-quenching effect. Such effects are based on the energy
transfer between fluorescent dyes that occurs at distances in the range of <10 nm [10,24,25]. In this
section, the relation between the thickness of the accumulating antibody and the fluorescent signals
obtained via secondary antibodies in arrays format was studied.
Serum reactive peptide was spotted in 3 dilutions (400 µM, 200 µM, and 100 µM) and incubated
with 7 concentrations of serum ranging from 1:800–1:12.5, resulting in 21 areas of 9 spots each (see
Figure 2). Human serum was serially diluted from 1:12.5–1:800 in PBS-T (PBS containing 0.05% v/v
Tween 20 (Sigma-Aldrich, St. LouisCity, MO, USA)) and incubated overnight at 4 ◦C. The slide
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was therefore divided into separated subarrays to avoid cross-contamination by using a press-on
sealing. The secondary antibody was incubated for 30 min. Finally, a fluorescently-labeled secondary
antibody was incubated at 13.3 nM. The array was scanned using VSI and fluorescence imaging
and obtained spot heights and spot fluorescence intensities for each field were averaged for 9 spots
respectively (Figure 5). As expected, peptide spots spotted at 100 µM resulted in lower protein layer
thickness than higher peptide concentrations. At a dilution of 1:100 for the 400 µM and 200 µM spots,
and 1:50 for the 100 µM spots, no further increase in protein layer thickness can be observed for higher
serum concentrations. At the same time, for dilutions lower than 1:100, the fluorescence intensity
decreases drastically.
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and secondary antibody for different dilutions of serum. Peptides were spotted in three different
co centrations: 400 µM, 200 µM, an 100 µM.






Whereby ∆h is the thickness and ∆hsat is the saturation thickness of the accumulated antibody layer,
δ(k) the distance between two macromolecules which is dependent of the serum dilution k, and λ/2 is
the optical resolution limit corresponding to the averaged wavelength λ used for the VSI. The physical
meaning of this formula consists in the averaging of the protein nanolayer thickness if the accumulated
molecules are separated by a relatively large distance. For example, if the distance between two
antibodies is λ/2, the average thickness of the accumulated layer will be ∆hsat/2. If the distance
between two antibodies is >>λ, the VSI will deal with separated molecules and no accumulation layer
will be detected: ∆h→ 0. As the fluorescent excitation/emission and the VSI wavelength are in the
visible range of the ord r of 500 nm and δ(k) ~ 10 nm in the region of the dye quenching, the ration
δ(k)/λ << 1 and, accordingly, th ∆h = ∆hsat. This explains why the sat r ion region of the antibody
thickness curve and the region of the fluorescent dye quenching are considered in the experiment.
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The experimental curves for VSI and fluorescence-based detection exhibit a linear dependence
of the measured signals at small k. This fact could be supported using Formula (1) and the
Michaelis–Menten equation [26] for the fluorescent signal I at large dilutions kN0 << KD (in our





Here, Isat is the saturation fluorescent signal, KD the dissociation constant of the peptide bound antibody
within the spot, and N0 is the concentration of the antibody in the serum. Taking into account that δ
is inversely proportional to the surface density of the accumulated molecules und correspondingly
inversely proportional to I, the dependence of δ(k) has the form: δ ~ 1/I ~ 1/k. Thus, ∆h ~ k in the case
of a strong dilution λ/2 << δ is observed in the experiment.
Thus, the VSI can be used for measurement of the protein accumulation thickness in a wide
range of protein concentrations. In the saturation region, the hight of the VSI profile corresponds
to the physical thickness of the protein layer and is independent of the density of the molecules
absorbed. In contrast, a linear dependence of layer thickness on the dilution takes place at large
dilutions, which can be resolved by VSI. In this case, the label-free VSI measurements can be used for
studying protein-protein kinetics in a high-density array format.
3.3. Spot Topology is Consistent for Measurements with AFM and VSI
If the VSI values correspond to the thickness of antibody accumulation layer, this thickness
should be detectable with alternative methods, such as atomic force microscopy (AFM), which is an
established method for surface characterization. For this purpose, a single spot was selected from the
experiment in Section 3.2 and measured by AFM with a lateral resolution of 76.1 nm/pixel and VSI
with a lateral resolution of 74.6 nm/pixel (Figure 6A). Since the exact coordinates of the spot were
determined in previous VSI scans, finding the position for the AFM measurement was easy, and the
measurement of the whole area took approximately 90 min. For the VSI measurement, an area of
96.06 µm by 95.91 µm was scanned at 50-fold magnification by stitching two times, resulting in 1288 by
1286 pixels. Both measurements were flattened and z-offset was adjusted as described in Section 2.5.
Both the AFM and VSI patterns look like concentric circles because the spot was formed via double
spotting. As the spotting occurs by contact with the surface, the material volume to be transferred
and the spreading of the droplets depend on the surface hydrophilicity. While the first spot was
transferred onto the 3D-Maleimide surface, the second spot contacted the material, predominately
peptides, transferred by the first spotting. The enhanced concentration of the optical density at the
edges of the spots observed in the experiment is known as the “coffee ring” effect [27].
To compare the absolute thickness profiles, 3 vertical and 3 horizontal profiles were extracted from
the respective measurements (Figure 6C). In general, the AFM profiles match the VSI profiles along
to the selected axes. However, the VSI scan appears to be minimally higher compared to the AFM
scan. This was also observed for other spots (see supplementary data, Figures S2 and S3). The AFM
profiles are noticeably more scattered than the VSI in blue, and for the horizontal profiles, the waviness
due to flattening is also visible. This is confirmed by comparing the shape of the respective histogram
(see Figure 6B), which is slightly slimmer for VSI, and noticeably jagged with a broader tailing for the
AFM. A superimposed frequency can be seen in the AFM based histogram as well. As a result, both
histograms cannot be matched exactly.
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4. Conclusions
Using VSI, thin protein layer profiles were studied on a large field of view by stitching several
scans while maintaining a vertical resolution of 0.1 nm. VSI was successfully applied to measure the
accumulation of the fluorescently-labeled secondary antibody in a dilution series of serum. For low
antibody concentrations, at which the distance between the absorbed antibodies is comparable
with the visible wavelength range, the VSI profiles demonstrate linear dependency on the antibody
concentration. This regime may be used for label-free detection of the peptide-protein kinetics in a
high-density array format. For large antibody concentrations at which the distance between antibodies
is much smaller than the size of optical resolution, the thickness of the antibody film is independent of
the further rise of antibody surface concentration. The measurement of the spot topologies via AFM
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has proved that the thickness obtained via VSI at saturation conditions corresponds to the real physical
thickness of the protein layers accumulated in the array format in the spots.
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